Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
Remdesivir exhibits in vitro activity against SARS-CoV-2 and was granted approval for emergency use. To maximize delivery to the lungs, we formulated remdesivir as a dry powder for inhalation using thin film freezing (TFF). TFF produces brittle matrix nanostructured aggregates that are sheared into...
Saved in:
Main Authors: | Sawittree Sahakijpijarn (Author), Chaeho Moon (Author), John J. Koleng (Author), Dale J. Christensen (Author), Robert O. Williams (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vivo pharmacokinetic study of remdesivir dry powder for inhalation in hamsters
by: Sawittree Sahakijpijarn, et al.
Published: (2021) -
Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations
by: Sagar R. Pardeshi, et al.
Published: (2022) -
A Safety and Tolerability Study of Thin Film Freeze-Dried Tacrolimus for Local Pulmonary Drug Delivery in Human Subjects
by: Sawittree Sahakijpijarn, et al.
Published: (2021) -
Formulation Composition and Process Affect Counterion for CSP7 Peptide
by: Sawittree Sahakijpijarn, et al.
Published: (2019) -
Screening of Cyclodextrins in the Processing of Buserelin Dry Powders for Inhalation Prepared by Spray Freeze-Drying
by: Mostafa Rostamnezhad, et al.
Published: (2023)